About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials | 4,270 Studies Recruiting

Clinical TrialsSchizophrenia

Schizophrenia Clinical Trials

Browse 4,270 clinical trials for schizophrenia. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 981-1000 of 4,270 trials

UnknownExpanding Rapid Ascertainment Network of Schizophrenia Families in TaiwanThis proposal responds to Request for Applications RFA-MH-08-131, which seeks applications that propose to enrich pre-existing resources for schizophrenia in the National…NCT01249079·Taichung CompletedHormonal and Inflammatory Biomarkers and Response to Cognitive Remediation in Recent-onset PsychosisThis study aims to explore whether hormones or inflammatory markers are associated with cognitive changes following cognitive remediation therapy (CRT) in people with a…NCT04418570

Related Searches

Data from ClinicalTrials.govTerms

CompletedTC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in SchizophreniaSchizophrenia affects approximately 1% of the population worldwide, and in about 80% of cases, it is a lifelong, disabling illness.NCT01003379·National City, California and 15 others

CompletedA Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With SchizophreniaThe purpose of this study is to evaluate the long-term safety and tolerability and the maintenance of effectiveness of a slow, extended-release oral formulation of paliperidone…NCT00210769

CompletedEffects of Antipsychotic Medications on Energy Intake and ExpenditureAim 1: To evaluate the effect of antipsychotic treatment group on Activity Energy Expenditure.NCT00836251·St Louis, Missouri

UnknownEvaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar DisorderAn open-label, randomized, active control inpatient trial to evaluate the efficacy and tolerability of sublingual dexmedetomidine for the treatment of agitation in inpatients with…NCT06093451·Philadelphia, Pennsylvania

CompletedA Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic MedicationThe purpose of this study was to evaluate the efficacy of ASP4345 on cognitive impairment compared to placebo using change from baseline in MATRICS Consensus Cognitive Battery…NCT03557931·Cerritos, California and 26 others

CompletedTarget Engagement and Response to OxytocinThis study will measure whether the engagement of intranasal oxytocin with a brain target is related to effects on learning during a social cognition training program.NCT03245437·Los Angeles, California

CompletedSafety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than AripiprazoleThis study will test the safety of an aripiprazole injection in subjects with schizophrenia that are currently taking oral antipsychotic medication other than aripiprazole.NCT01552772·Anaheim, California and 11 others

Active not recruitingEffects of a Peer-facilitated, Recovery-focused Self-illness Management Program for First-episode PsychosisPsychosis is a major disabling and disruptive mental illness characterized by a wide variety of disturbances in cognition and emotions, resulting in poor psychosocial functioning…NCT06487195·Hong Kong

CompletedThe Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic PatientsThe lifetime of substance use disorders in schizophrenia is close to 50%. Substance abuse in schizophrenia is associated with negative consequences.NCT00295412·Montreal, Quebec

CompletedThe Effect of Recognition and Expression of Emotions Program Applied to Schizophrenia PatientsAs a result of the positive and negative symptoms that occur in schizophrenia, patients with schizophrenia may experience negative emotions more frequently than individuals with…NCT05662137·Sinop

CompletedClozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic PatientsApproximately 30-60% of all schizophrenia patients who fail to respond to typical antipsychotics may respond to Clozapine.NCT01663077·Tirat Carmel

TerminatedDetermining the Safety and Effectiveness of Olanzapine in Children and AdolescentsThis study will examine the safety and effectiveness of the antipsychotic drug olanzapine in children and adolescents with bipolar disorder or psychosis.NCT00183612·Belmont, Massachusetts and 1 other

CompletedEvaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMIThe goal of this project, which has not changed, is to evaluate the statewide implementation of a two-component intervention (health promotion plus academic detailing) with…NCT02334280·Lebanon, New Hampshire and 3 others

TerminatedA Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.The purpose of this study is to understand safety and tolerability of the drug GSK1018921 after 14 days of dosing in healthy volunteers and then in patient volunteers.NCT00929370·Glendale, California and 1 other

CompletedRandomized Controlled Trial (RCT) of a Motivational Decision Support SystemIn this study we will definitively test the decision support system in a randomized controlled trial (RCT) among smokers with severe mental illness (SMI) psychotic disorders.NCT02086162·Chicago, Illinois and 2 others

UnknownHippotherapy in Patients With SchizophreniaThis study will determine the efficacy of hippotherapy (horseback-riding) program, as an adjuvant to standard psychiatric treatment, on the outcomes of patients with schizophrenia.NCT06303596·Erzurum

Not yet recruitingThe Effect of Salutogenic-based Interviewing on Subjective Recovery and Quality of Life in SchizophreniaSchizophrenia is an inherited, complex, multidimensional syndrome with varying degrees of psychotic, negative, cognitive, mood and motor symptoms.NCT06820580·Elâzığ, Province

CompletedCognitive and Emotional Factors in Visual Exploration Among Patients With SchizophreniaBackground: Patients with schizophrenia are abnormally disturbed by information onsets, which may result in a disadvantage in filtering relevant information.NCT02874482·Lille

PreviousPage 50 of 214Next